• Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Live Link
    • Truveta Studio
  • Genomics
  • Solutions
    • Medical devices
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • News
    • Careers

Get started
Sign in
Close
Real-time monitoring of viral gastroenteritis: April 2024

Real-time monitoring of viral gastroenteritis: April 2024

by Truveta Research | May 22, 2024 | Research

Norovirus and rotavirus are significant contributors to gastrointestinal infections worldwide, creating risk for patient populations and strain on the healthcare system. Truveta Research evaluated trends in norovirus- and rotavirus-associated hospitalizations overall...
New insights from family history can shed light on prostate cancer

New insights from family history can shed light on prostate cancer

by Truveta staff | May 20, 2024 | Research

You probably know someone who will be diagnosed with prostate cancer in their lifetime. 1 in 8 men will develop prostate cancer, with a higher risk in Black and African American men and an overall increased risk after the age of 65. While most cases are not fatal,...
Truveta Data used in new study shows women and Black patients less likely to receive catheter-based treatment for pulmonary embolism

Truveta Data used in new study shows women and Black patients less likely to receive catheter-based treatment for pulmonary embolism

by Truveta staff | May 13, 2024 | Research

Recently, researchers presented new insights from a continued analysis of the REAL-PE study at the Society for Cardiovascular Angiography and Interventions (SCAI) 2024 meeting. To address a lack of sufficient clinical guidance on how to best treat pulmonary embolism...
Real-world prescribing of lecanemab in the United States

Real-world prescribing of lecanemab in the United States

by Truveta Research | May 6, 2024 | Research, Research Insights

Authors: Brianna M. Goodwin Cartwright, MS ⊕Truveta, Inc, Bellevue, WA, Patricia J. Rodriguez, PhD MPH ⊕Truveta, Inc, Bellevue, WA, Samuel Gratzl, PhD ⊕Truveta, Inc, Bellevue, WA, Charlotte Baker, DrPH MPH CPH ⊕Truveta, Inc, Bellevue, WA, Nicholas Stucky, MD PhD...
Baseline A1C and BMI trends for people with type 2 diabetes receiving first-time GLP-1 RA prescriptions

Baseline A1C and BMI trends for people with type 2 diabetes receiving first-time GLP-1 RA prescriptions

by Truveta Research | May 6, 2024 | Research, Research Insights

Authors: Brianna M. Goodwin Cartwright ⊕Truveta, Inc, Bellevue, WA, Patricia J. Rodriguez, PhD MPH ⊕Truveta, Inc, Bellevue, WA, Samuel Gratzl PhD ⊕Truveta, Inc, Bellevue, WA, Charlotte Baker DrPH MPH CPH ⊕Truveta, Inc, Bellevue, WA, Christopher M. Worsham, MD MPH...
New research uses Truveta Data to study the management of patients with acute heart failure

New research uses Truveta Data to study the management of patients with acute heart failure

by Truveta staff | May 2, 2024 | Research

Leading heart failure researchers have published new research in JACC: Heart Failure. The TREAT-AHF study found that despite significant efforts to improve acute heart failure treatment over the past 20 years, management remains unchanged. Reprieve Cardiovascular is...
« Older Entries
Next Entries »

Share this


Recent posts

  • Estrogen-based hormone replacement therapy use is rising
  • Four real-world insights reshaping urology: New evidence from Boston Scientific
  • University of Michigan study sets a new benchmark for cervical cancer screening in the US

Follow Truveta


Sign up for our newsletter

Ready to accelerate your research with representative, complete, and timely real-world data?

Truveta Data

Truveta Genome Project

Research

Resources

Blog

News

Careers

Privacy notice

Contact us

© Truveta 2026

Our website uses cookies to ensure you have the best experience.